CBDCA and PIXY321 Effects on Platelet Counts
Comparison (study portion-cycle)* . | No. of Patients . | Mean Platelet Nadir (1,000 cells/μL)† . | P Value . | Mean Days of Platelets <20,000/μL† . | P Value . | Mean Days to Platelets >100,000/μL† . | P Value . |
---|---|---|---|---|---|---|---|
A-1 v A-2 | 20v 20 | 28 (±5) v 39 (±7) | .07 | 1.6 (±0.5) v 1.0 (±0.4) | .06 | 20 (±1)v 18 (±1) | .08 |
A-1 v B-1 | 20v 11 | 28 (±5) v 53 (±21) | .13 | 1.6 (±0.5) v 1.6 (±0.6) | 1.00 | 20 (±1)v 15 (±2) | .01 |
B-1 v B-2 | 11 v 11 | 53 (±21) v 21 (±6) | .06 | 1.6 (±0.6) v 1.5 (±0.5) | 1.00 | 15 (±2)v 22 (±1) | .03 |
A-2 v B-2 | 20 v 11 | 39 (±7) v 21 (±6) | .08 | 1.0 (±0.4) v 1.5 (±0.5) | .54 | 18 (±1)v 22 (±1) | .13 |
Comparison (study portion-cycle)* . | No. of Patients . | Mean Platelet Nadir (1,000 cells/μL)† . | P Value . | Mean Days of Platelets <20,000/μL† . | P Value . | Mean Days to Platelets >100,000/μL† . | P Value . |
---|---|---|---|---|---|---|---|
A-1 v A-2 | 20v 20 | 28 (±5) v 39 (±7) | .07 | 1.6 (±0.5) v 1.0 (±0.4) | .06 | 20 (±1)v 18 (±1) | .08 |
A-1 v B-1 | 20v 11 | 28 (±5) v 53 (±21) | .13 | 1.6 (±0.5) v 1.6 (±0.6) | 1.00 | 20 (±1)v 15 (±2) | .01 |
B-1 v B-2 | 11 v 11 | 53 (±21) v 21 (±6) | .06 | 1.6 (±0.6) v 1.5 (±0.5) | 1.00 | 15 (±2)v 22 (±1) | .03 |
A-2 v B-2 | 20 v 11 | 39 (±7) v 21 (±6) | .08 | 1.0 (±0.4) v 1.5 (±0.5) | .54 | 18 (±1)v 22 (±1) | .13 |